Literature DB >> 8672971

Small hepatocellular carcinoma: differentiation from adenomatous hyperplasia with color Doppler US and dynamic Gd-DTPA-enhanced MR imaging.

R Lencioni1, M Mascalchi, D Caramella, C Bartolozzi.   

Abstract

BACKGROUND: To investigate the usefulness of color Doppler ultrasound (US) and dynamic Gd-DTPA-enhanced magnetic resonance (MR) imaging in the differentiation of small hepatocellular carcinoma (HCC) and adenomatous hyperplasia (AH).
METHODS: Thirty-eight small (3 cm or less) nodular lesions (in 38 cirrhotic patients) with US features consistent with HCC underwent evaluation with color Doppler US and MR imaging. Breath-hold T1-weighted rapid acquisition spin echo MR sequence after bolus injection of 0.1 mmol/kg gadopentetate dimeglumine was used to evaluate dynamic enhancement. US-guided tissue-core percutaneous biopsy established the diagnosis: HCC in 28 cases and AH in 10.
RESULTS: Color signals with pulsatile or continuous Doppler spectrum were demonstrated in 19 of 28 HCCs (68%) but in none of the AHs. Although there was considerable overlap in signal intensity between HCC and AH on both unenhanced T1- and T2-weighted images, early enhancement on breath-hold T1-weighted images obtained 40 s after starting contrast administration was observed in 22 of 28 HCCs (79%) but in none of the AHs. In 26 of 28 HCCs (93%), pulsatile or continuous flow at color Doppler US, early enhancement at dynamic MR imaging, or both were observed.
CONCLUSION: Findings with color Doppler US and dynamic Gd-DTPA-enhanced MR imaging enable a reliable distinction between small HCC and AH.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8672971     DOI: 10.1007/s002619900007

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  7 in total

Review 1.  Ethanol injection for the treatment of hepatic tumours.

Authors:  C Bartolozzi; R Lencioni
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

2.  Contrast-enhanced ultrasonographic imaging diagnosis on assessment of vascularity in liver metastatic lesions.

Authors:  Wen-Hua Du; Wei-Xiao Yang; Xiu-Qin Xiong; Xiang Wang; Yi Zhou; Hui Wang
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

Review 3.  Guide for diagnosis and treatment of hepatocellular carcinoma.

Authors:  Magdy Hamed Attwa; Shahira Aly El-Etreby
Journal:  World J Hepatol       Date:  2015-06-28

4.  Correlation of pretreatment polarographically measured oxygen pressures with quantified contrast-enhanced power doppler ultrasonography in spontaneous canine tumors and their impact on outcome after radiation therapy.

Authors:  Carla Rohrer Bley; Dagmar Laluhova; Malgorzata Roos; Barbara Kaser-Hotz; Stefanie Ohlerth
Journal:  Strahlenther Onkol       Date:  2009-11-10       Impact factor: 3.621

Review 5.  Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring.

Authors:  Tiffany Hennedige; Sudhakar Kundapur Venkatesh
Journal:  Cancer Imaging       Date:  2013-02-08       Impact factor: 3.909

Review 6.  Tumor Hemodynamics and Hepatocarcinogenesis: Radio-Pathological Correlations and Outcomes of Carcinogenic Hepatocyte Nodules.

Authors:  Kazuhiko Ueda; Osamu Matsui; Azusa Kitao; Satoshi Kobayashi; Jun Nakayama; Shinich Miyagawa; Masumi Kadoya
Journal:  ISRN Hepatol       Date:  2014-03-03

7.  Size measurements of hepatocellular carcinoma: comparisons between contrast and two-dimensional ultrasound.

Authors:  Fei Chen; Fei Wang; Si Sun; Mei Zhu; Zheng Liu
Journal:  BMC Gastroenterol       Date:  2020-11-19       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.